1
|
Ke Q and Costa M: Hypoxia-inducible
factor-1 (HIF-1). Mol Pharmacol. 70:1469–1480. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Leung KW, Ng HM, Tang MK, Wong CC, Wong RN
and Wong AS: Ginsenoside-Rg1 mediates a hypoxia-independent
upregulation of hypoxia-inducible factor-1α to promote
angiogenesis. Angiogenesis. 14:515–522. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Liao D, Corle C, Seagroves TN and Johnson
RS: Hypoxia-inducible factor-1alpha is a key regulator of
metastasis in a transgenic model of cancer initiation and
progression. Cancer Res. 67:563–572. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Frolova O, Samudio I, Benito JM, et al:
Regulation of HIF-1α signaling and chemoresistance in acute
lymphocytic leukemia under hypoxic conditions of the bone marrow
microenvironment. Cancer Biol Ther. 13:858–870. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ryan HE, Lo J and Johnson RS: HIF-1 alpha
is required for solid tumor formation and embryonic
vascularization. EMBO J. 17:3005–3015. 1998. View Article : Google Scholar : PubMed/NCBI
|
6
|
Onnis B, Rapisarda A and Melillo G:
Development of HIF-1 inhibitors for cancer therapy. J Cell Mol Med.
13:2780–2786. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sapra P, Kraft P, Pastorino F, et al:
Potent and sustained inhibition of HIF-1α and downstream genes by a
polyethyleneglycol-SN38 conjugate, EZN-2208, results in
anti-angiogenic effects. Angiogenesis. 14:245–253. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Abdollahi A, Hahnfeldt P, Maercker C, et
al: Endostatin’s antiangiogenic signaling network. Mol Cell.
13:649–663. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
O’Reilly MS, Boehm T, Shing Y, et al:
Endostatin: an endogenous inhibitor of angiogenesis and tumor
growth. Cell. 88:277–285. 1997. View Article : Google Scholar
|
10
|
Abdollahi A, Hlatky L and Huber PE:
Endostatin: the logic of antiangiogenic therapy. Drug Resist Updat.
8:59–74. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
MacDonald NJ, Shivers WY, Narum DL, et al:
Endostatin binds tropomyosin. A potential modulator of the
antitumor activity of endostatin. J Biol Chem. 276:25190–25196.
2001. View Article : Google Scholar : PubMed/NCBI
|
12
|
Karumanchi SA, Jha V, Ramchandran R, et
al: Cell surface glypicans are low-affinity endostatin receptors.
Mol Cell. 7:811–822. 2001. View Article : Google Scholar : PubMed/NCBI
|
13
|
Shi H, Huang Y, Zhou H, et al: Nucleolin
is a receptor that mediates antiangiogenic and antitumor activity
of endostatin. Blood. 110:2899–2906. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chen Y, Wang S, Lu X, Zhang H, Fu Y and
Luo Y: Cholesterol sequestration by nystatin enhances the uptake
and activity of endostatin in endothelium via regulating distinct
endocytic pathways. Blood. 117:6392–6403. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Song N, Ding Y, Zhuo W, et al: The nuclear
translocation of endostatin is mediated by its receptor nucleolin
in endothelial cells. Angiogenesis. 15:697–711. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Han Q, Fu Y, Zhou H, He Y and Luo Y:
Contributions of Zn(II)-binding to the structural stability of
endostatin. FEBS Lett. 581:3027–3032. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Song N, Huang Y, Shi H, et al:
Overexpression of platelet-derived growth factor-BB increases tumor
pericyte content via stromal-derived factor-1alpha/CXCR4 axis.
Cancer Res. 69:6057–6064. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Toffoli S, Roegiers A, Feron O, et al:
Intermittent hypoxia is an angiogenic inducer for endothelial
cells: role of HIF-1. Angiogenesis. 12:47–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Calvani M, Rapisarda A, Uranchimeg B,
Shoemaker RH and Melillo G: Hypoxic induction of an
HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in
human endothelial cells. Blood. 107:2705–2712. 2006. View Article : Google Scholar
|
20
|
Chen MC, Lee CF, Huang WH and Chou TC:
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of
HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Biochem Pharmacol. 85:1278–1287. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ding YH, Javaherian K, Lo KM, et al:
Zinc-dependent dimers observed in crystals of human endostatin.
Proc Natl Acad Sci USA. 95:10443–10448. 1998. View Article : Google Scholar : PubMed/NCBI
|
22
|
Fu Y and Luo Y: The N-terminal integrity
is critical for the stability and biological functions of
endostatin. Biochemistry. 49:6420–6429. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Nyborg JK and Peersen OB: That zincing
feeling: the effects of EDTA on the behaviour of zinc-binding
transcriptional regulators. Biochem J. 381:e3–e4. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Fu Y, Tang H, Huang Y, Song N and Luo Y:
Unraveling the mysteries of endostatin. IUBMB Life. 61:613–626.
2009. View
Article : Google Scholar : PubMed/NCBI
|